NHL

Showing NaN - NaN of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021